COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 658: Articles 6571-6580  | Next

Vaccine, Booster and Natural Antibody Binding to SARS-CoV-2 Omicron (BA.1) Spike Protein and Vaccine Efficacy
James-Pemberton, P. H., Helliwell, M. W., Olkhov, R. V., Kohli, S., Westlake, A. C., Farrar, B. M., Sutton, B. J., Ager, N. D., Shaw, A. M.
10.1101/2022.07.12.22277539 — Posted: 2022-07-15
Upregulation of Activation Induced Cell Markers (AIM) among Severe COVID-19 patients in Bangladesh
Bhuiyan, T. R., Banna, H. A., Kaisar, M. H., Karmakar, P. C., Hakim, A., Akter, A., Ahmed, T., Tauheed, I., Islam, S., Hasnat, M. A., Sumon, M. A., Rashed, A., Ghosh, S., Clemens, J. D., Banu, S., Shirin, T., Weiskopf, D., Sette, A., Chowdhury, F., Qadri, F.
10.1101/2022.07.12.22276726 — Posted: 2022-07-15
SARS-CoV-2 exhibits extreme differences in early viral loads among specimen types suggesting improved detection of pre-infectious and infectious individuals using combination specimen types
Viloria Winnett, A., Akana, R., Shelby, N., Davich, H., Caldera, S., Yamada, T., Reyna, J. R. B., Romano, A. E., Carter, A. M., Kim, M. K., Thomson, M., Tognazzini, C., Feaster, M., Goh, Y.-Y., Chew, Y. C., Ismagilov, R. F.
10.1101/2022.07.13.22277113 — Posted: 2022-07-15
Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: Findings from a Mendelian randomisation study
Hamilton, F. W., Thomas, M., Arnold, D. T., Palmer, T. M., Moran, E., Mentzer, A. J., Maskell, N. A., Baillie, J. K., Summers, C., Hingorani, A. D., MacGowan, A. P., Khandaker, G. M., Mitchell, R. E., Davey Smith, G., Ghazal, P., Timpson, N. J.
10.1101/2022.07.14.22277638 — Posted: 2022-07-15
Long COVID in Cancer patients: Preponderance of Symptoms in Majority of Patients over Long Time Period
Dagher, H., Chaftari, A.-M., Subbiah, I. M., Malek, A. E., Jiang, Y., Lamie, P., Granwehr, B., John, T., Yepez, E., Borjan, J., Reyes, C., Flores, M., Khawaja, F., Pande, M., Ali, N., Rojo, R., Karp, D. D., Hachem, R., Raad, I. I.
10.1101/2022.07.13.22277579 — Posted: 2022-07-15
Detection of pneumococcus during hospitalization for SARS-CoV-2
Watkins, A. E., Glick, L. R., Ott, I. M., Craft, S. B., Yolda-Carr, D., Harden, C. A., Nakahata, M., Farhadian, S. F., Grant, L. R., Alexander-Parrish, R., Arguedas, A., Gessner, B. D., Weinberger, D. M., Wyllie, A. L.
10.1101/2022.07.13.22277607 — Posted: 2022-07-15
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
Becker, M., Cossmann, A., Luerken, K., Junker, D., Gruber, J., Juengling, J., Morillas Ramos, G., Beigel, A., Jablonka, A., Wrengert, E., Lonnemann, G., Stankov, M. V., Kaiser, P. D., Traenkle, B., Rothbauer, U., Krause, G., Schneiderhan-Marra, N., Strengert, M., Dulovic, A., Behrens, G. M. N.
10.1101/2022.07.13.22277581 — Posted: 2022-07-15
Extreme differences in SARS-CoV-2 Omicron viral loads among specimen types drives poor performance of nasal rapid antigen tests for detecting presumably pre-infectious and infectious individuals, predicting improved performance of combination specimen antigen tests
Viloria Winnett, A., Akana, R., Shelby, N., Davich, H., Caldera, S., Yamada, T., Reyna, J. R. B., Romano, A. E., Carter, A. M., Kim, M. K., Thomson, M., Tognazzini, C., Feaster, M., Goh, Y.-Y., Chew, Y. C., Ismagilov, R. F.
10.1101/2022.07.13.22277513 — Posted: 2022-07-15
Fully Quantitative Measurements of the Antibody Levels for SARS-CoV-2 Infections and Vaccinations calibrated against the NISTmAb Standard IgG Antibody
James-Pemberton, P. H., Helliwell, M. W., Olkhov, R. V., Kohli, S., Westlake, A. C., Farrar, B. M., Shaw, A.
10.1101/2022.07.12.22277533 — Posted: 2022-07-15
Bubble-PAPR: Phase I clinical evaluation of an in-house developed prototype powered air-purifying respirator for use by healthcare workers
McGrath, B. A., Shelton, C. L., Gardner, A., Coleman, R., Lynch, J., Alexander, P. G., Cooper, G.
10.1101/2022.07.14.22277643 — Posted: 2022-07-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).